A mother’s diet can protect her grandchildren’s brains: genetic model study
Posted: 7 August 2023 Mothers who eat apples and herbs in early pregnancy could be protecting the brain health of their children and grandchildren, a Monash University study using genetic models has found. The discovery is part of…
3D digital technologies tackling mental injury prevention in health care
Posted: 7 August 2023 Designers have 3D-knitted bespoke hospital scrubs and 3D printed chill out pods for busy healthcare workers to improve their comfort and workplace mental health. The Safety Sensescaping project, funded by WorkSafe’s WorkWell Mental Health Improvement Fund,…
ACCENT Trial Recruitment Update
Posted: 7 August 2023 Amplia Therapeutics Limited (ASX: ATX), (“Amplia” or the “Company”), is pleased to provide an update on progress in the ongoing Phase 1b/2a ACCENT clinical trial in first-line patients with advanced pancreatic cancer. The current…
$16.7 million vote of confidence in Melbourne-developed cancer detection system
Posted: 7 August 2023 A major investment in a Melbourne-based healthcare technology developer will underpin the launch of a world-first live microscopic imaging device for oral cancer. Optiscan Imaging Limited (ASX: OIL) has developed a miniaturised, handheld technology…
Immutep Receives Positive Scientific Advice from European Medicines Agency
Posted: 7 August 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces it has received positive scientific advice from the Committee…
$64 million in funding for new ARC Industrial Transformation Training Centres and ARC Industrial Transformation Research Hubs
Posted: 7 August 2023 More than $64.8 million in funding has been awarded to 8 new Australian Research Council (ARC) Industrial Transformation Training Centres and 5 new ARC Industrial Transformation Research Hubs to mentor and train Australia’s next…
The University of Melbourne and Peter Mac to establish precision cancer care centre
Posted: 2 August 2023 The University of Melbourne and the Peter MacCallum Cancer Centre will establish a new centre to transform how genomics and precision oncology is delivered in Australia. A memorandum of understanding (MoU) to establish the…
Immune cell discovery could lead to improved chronic worm treatment
Posted: 2 August 2023 Monash University researchers have uncovered why some intestinal worm infections become chronic in animal models, which could eventually lead to human vaccines and improved treatments. Parasitic worms, also called helminths, usually infect the host…
Partnered program update
Posted: 1 August 2023 Following communication from AstraZeneca on Friday, 28 July 2023, and the subsequent release of AstraZeneca’s H1 and Q2 2023 results announcement that day, Starpharma (ASX: SPL, OTCQX: SPHRY) reports that AstraZeneca has made the…
First Patient Dosed in Chemotherapy-Free Triple Combination Phase II Trial Targeting Soft Tissue Sarcoma
Posted: 1 August 2023 Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a clinical-stage biotechnology company developing novel LAG-3 immunotherapies for cancer and autoimmune disease, today announces the first patient has been enrolled and safely dosed in…
Scientific breakthrough harnesses mRNA technology to develop powerful malaria vaccine
Posted: 1 August 2023 A new mRNA vaccine targeting immune cells in the liver could be the key to tackling malaria, a disease that causes over half a million deaths each year according to the World Health Organization,…
Advanced Cell Therapy Manufacturing Initiative to be established in Brisbane
Posted: 1 August 2023 CCRM Australia, with its Canadian partners OmniaBio Inc. and Toronto-based CCRM, has signed a Letter of Intent with The University of Queensland to establish the Advanced Cell Therapy Manufacturing Initiative (ACTMI) at the St…
